Metabasis Therapeutics, Inc. Announces Second Quarter 2009 Financial Results
SAN DIEGO--(BUSINESS WIRE)--Metabasis Therapeutics, Inc. (Nasdaq: MBRX), a biopharmaceutical company that has established an existing pipeline of product candidates and advanced discovery programs targeting large markets with significant unmet needs including hyperlipidemia, diabetes and HCV, today announced financial results for the second quarter and six months ended June 30, 2009.